Target intelligence / Profile preview

Novel transcript, antisense to Spindlin 1 (ENSG00000287769)

Target
ENSG00000287769
Molecular classification
Non-coding RNA, Natural antisense transcript (NAT), Other (intergenic transcript)
01

Overview

This molecule is a natural antisense non-coding RNA transcript complementary to the SPIN1 (Spindlin 1) gene. NATs like ENSG00000287769 are transcribed from the DNA strand opposite a protein-coding gene and are implicated in the regulation of gene expression, chromatin state, and mRNA processing. Although such transcripts can influence biological processes including cell proliferation and disease pathways, the specific regulatory roles, functional significance, and therapeutic potential of the "novel transcript, antisense to SPIN1" have not been experimentally elucidated as of the time of writing. It remains primarily a research interest, not a conventional therapeutic target[1][3][5][7][8][9].

Other names
LOC124902204ENSG00000287769
02

Mechanism of action

Not established. General mechanisms for antisense transcripts involve RNA-based regulation, but no agents targeting this specific NAT are known.

03

Biological functions

Regulation of gene expressionChromatin modificationRNA processingMasking miRNA-binding sitesOther possible regulatory effects specific to SPIN1 are not yet well described.
04

Disease associations

Cancer (NATs, including those regulating SPIN1, may influence cancer pathways, but no specific disease role for this antisense transcript is documented)Other: Unclear; no explicit links to additional pathologies.
05

Safety considerations

None documented. NATs can be challenging targets due to tissue specificity and complexity of RNA-based regulation.
06

Biomarkers

None described. NATs are occasionally explored as biomarkers in research contexts, but no established biomarker status for this transcript.

Beyond the preview

Go deeper on Novel transcript, antisense to Spindlin 1 (ENSG00000287769).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novel transcript, antisense to Spindlin 1 (ENSG00000287769).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call